This is the second policy test blog. #Policy
This is a test post for the policy blog. #Policy
no search term matches found in comments.
Available here are the presentation slides and video recordings from the Thursday, September 5, 2019 Adoptive Cellular Therapies Workshop. In the wake of the 2017 U.S. Food and Drug Administration approvals for Chimeric Antigen Receptor (CAR) T cell therapies for the treatment of patients with...
Available here are the presentation slides and video recordings from the Friday, September 6, 2019 Adoptive Cellular Therapies Workshop. In the wake of the 2017 U.S. Food and Drug Administration approvals for Chimeric Antigen Receptor (CAR) T cell therapies for the treatment of patients with...
Immuno-Oncology Policy Working Group The Immuno-Oncology Policy Working Group launched in December 2015 to develop a strategic policy plan to accelerate progress for immune-oncology in multiple disease types and settings. SITC is co-leading this initiative, joining Friends of Cancer Research ,...
21st Century Cures Act On December 7, 2016, the U.S. Senate approved the 21st Century Cures Act, a wide-ranging health bill whose passage ensured the American government's commitment to curing cancer. President Barack Obama signed the bill into law soon there after. The 21st Century Cures Act...
SITC leaders have prioritized Adverse Events Reporting, Clinical Trial Design/Endpoints and Combination Approaches in approaching regulatory issues relating to the field of cancer immunotherapy. Society for Immunotherapy of Cancer (SITC) leaders have prioritized the following areas of focus in...
SITC is the first and only organization dedicated to cancer immunotherapy to be accepted as a formal member of the Commission on Cancer (CoC), a program of the American College of Surgeons. SITC 2019 Quality Summit Consensus Report Published on Jan. 16, 2020, in the Journal for ImmunoTherapy of...
Learn about how the Society for Immunotherapy of Cancer advocating toward the advancement of cancer immunotherapy research. Activities include Joe Biden's Cancer Moonshot Initiative, 21st Century Cures Act and more.
The Journal for ImmunoTherapy of Cancer (JITC) is the official journal of the Society for Immunotherapy of Cancer. This open access, peer-reviewed journal publishes original research articles, literature reviews, position papers and more on all aspects of tumor immunology and cancer...
Tel: +1 414 271 2456 | Fax: +1 414 276 3349 | Email: email@example.com